Equities analysts expect Cavium, Inc. (NASDAQ:CAVM) to report $260.18 million in sales for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have provided estimates for Cavium’s earnings, with the highest sales estimate coming in at $261.81 million and the lowest estimate coming in at $258.50 million. Cavium posted sales of $226.15 million in the same quarter last year, which suggests a positive year-over-year growth rate of 15%. The business is scheduled to report its next quarterly earnings results on Wednesday, February 7th.

According to Zacks, analysts expect that Cavium will report full-year sales of $260.18 million for the current year, with estimates ranging from $982.10 million to $985.47 million. For the next year, analysts forecast that the business will post sales of $1.11 billion per share, with estimates ranging from $1.09 billion to $1.13 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow Cavium.

Cavium (NASDAQ:CAVM) last posted its earnings results on Wednesday, November 1st. The semiconductor provider reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.74 by $0.02. The firm had revenue of $251.99 million for the quarter, compared to analysts’ expectations of $250.16 million. Cavium had a negative net margin of 19.94% and a positive return on equity of 11.16%. The company’s revenue was up 49.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.43 earnings per share.

A number of research firms have weighed in on CAVM. Jefferies Group set a $79.00 target price on shares of Cavium and gave the stock a “buy” rating in a research note on Thursday, October 19th. Benchmark cut shares of Cavium from a “buy” rating to a “hold” rating in a research note on Monday, November 20th. MKM Partners reissued a “buy” rating and issued a $81.00 price objective on shares of Cavium in a research note on Wednesday, August 16th. Loop Capital reissued a “buy” rating and issued a $81.00 price objective on shares of Cavium in a research note on Tuesday, August 22nd. Finally, Needham & Company LLC reissued a “buy” rating and issued a $78.00 price objective on shares of Cavium in a research note on Thursday, November 2nd. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Cavium has an average rating of “Hold” and an average price target of $78.41.

In other Cavium news, VP Anil Kumar Jain sold 8,500 shares of the company’s stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $85.90, for a total transaction of $730,150.00. Following the sale, the vice president now owns 91,616 shares of the company’s stock, valued at $7,869,814.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Vincent P. Pangrazio sold 15,000 shares of the company’s stock in a transaction on Friday, November 10th. The shares were sold at an average price of $77.22, for a total transaction of $1,158,300.00. Following the sale, the senior vice president now directly owns 60,039 shares in the company, valued at approximately $4,636,211.58. The disclosure for this sale can be found here. Corporate insiders own 4.65% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the business. Solaris Asset Management LLC boosted its position in Cavium by 43.4% during the second quarter. Solaris Asset Management LLC now owns 2,295 shares of the semiconductor provider’s stock valued at $143,000 after acquiring an additional 695 shares during the last quarter. BNP Paribas Arbitrage SA raised its holdings in shares of Cavium by 107.3% during the second quarter. BNP Paribas Arbitrage SA now owns 2,579 shares of the semiconductor provider’s stock valued at $160,000 after purchasing an additional 1,335 shares during the period. World Asset Management Inc acquired a new position in shares of Cavium during the third quarter valued at about $203,000. Tudor Investment Corp ET AL acquired a new position in shares of Cavium during the second quarter valued at about $228,000. Finally, Pacad Investment Ltd. raised its holdings in shares of Cavium by 42.3% during the second quarter. Pacad Investment Ltd. now owns 3,700 shares of the semiconductor provider’s stock valued at $230,000 after purchasing an additional 1,100 shares during the period.

Cavium (NASDAQ:CAVM) traded down $0.04 during midday trading on Wednesday, hitting $87.56. 1,856,500 shares of the company’s stock were exchanged, compared to its average volume of 1,024,229. The company has a market capitalization of $6,060.00, a PE ratio of 82.22, a PEG ratio of 3.20 and a beta of 1.27. Cavium has a 12-month low of $53.76 and a 12-month high of $88.96. The company has a current ratio of 2.87, a quick ratio of 2.27 and a debt-to-equity ratio of 0.81.

COPYRIGHT VIOLATION WARNING: This report was originally published by Daily Political and is the property of of Daily Political. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://www.dailypolitical.com/2017/11/29/zacks-analysts-anticipate-cavium-inc-cavm-will-post-quarterly-sales-of-260-18-million.html.

Cavium Company Profile

Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.

Get a free copy of the Zacks research report on Cavium (CAVM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cavium Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium Inc. and related companies with MarketBeat.com's FREE daily email newsletter.